
Life Image
Total Raised
$75MInvestors Count
9Deal Terms
2Funding, Valuation & Revenue
13 Fundings
Life Image has raised $75M over 13 rounds.
Life Image's latest funding round was a Acquired for on September 15, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
9/15/2022 | Acquired | 10 | ||||
4/11/2020 | Loan | $1.5M | ||||
4/5/2018 | Series E | $6.5M | MassVentures, and Undisclosed Investors | 1 | ||
9/24/2015 | Series D - II | |||||
5/28/2015 | Series D |
Date | 9/15/2022 | 4/11/2020 | 4/5/2018 | 9/24/2015 | 5/28/2015 |
|---|---|---|---|---|---|
Round | Acquired | Loan | Series E | Series D - II | Series D |
Amount | $1.5M | $6.5M | |||
Investors | MassVentures, and Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 10 | 1 |
Life Image Deal Terms
2 Deal Terms
Life Image's deal structure is available for 2 funding rounds, including their Series B - II from December 14, 2011.
Round | Series B - II | Series A - II |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B - II | |||||||||||||||
Series A - II |
Life Image Investors
9 Investors
Life Image has 9 investors. Intelerad invested in Life Image's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/15/2022 | 9/15/2022 | 1 Acquired | Corporation | North Carolina | ||
Government | DC | |||||
Venture Capital | Massachusetts | |||||
Corporate Venture | Massachusetts | |||||
Venture Capital | Massachusetts |
First funding | 9/15/2022 | ||||
|---|---|---|---|---|---|
Last Funding | 9/15/2022 | ||||
Investor | |||||
Rounds | 1 Acquired | ||||
Board Seats | |||||
Type | Corporation | Government | Venture Capital | Corporate Venture | Venture Capital |
Location | North Carolina | DC | Massachusetts | Massachusetts | Massachusetts |
Life Image Acquisitions
1 Acquisition
Life Image acquired 1 company. Their latest acquisition was Mammosphere on January 26, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/26/2016 | Acquired | 1 |
Date | 1/26/2016 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 1 |
Compare Life Image to Competitors

Segmed provides de-identified medical imaging data for the life sciences and technology sectors. The company has a real-world data network that allows for discovery and investigational capabilities in imaging data, supports the development of early disease detection and prediction models, assists in patient recruitment, and addresses the need for accessing therapeutic data ecosystems. Segmed serves the pharmaceutical, medical devices, and technology industries requiring clinical data. It was founded in 2019 and is based in Palo Alto, California.
Crisalix provides 3D visualization solutions for the aesthetic and reconstructive surgery sectors. The company offers a platform that allows patients to visualize potential outcomes of cosmetic and reconstructive procedures, and is used by healthcare professionals to educate patients and plan treatments. It was founded in 2008 and is based in Lausanne, Switzerland.

MVision AI specializes in the development of artificial intelligence (AI) powered tools for radiotherapy treatment. The company offers solutions automating and standardizing the contouring process in radiotherapy, aiming to improve efficiency and maintain standards. MVision AI's products are designed to reduce manual contouring time, increase consistency in treatment planning, and support continuous education for clinical teams. It was founded in 2017 and is based in Helsinki, Finland.

Brainlab develops digital medical technology focusing on medical technology. The company provides solutions digitising medical workflows from diagnosis to therapy, utilizing artificial intelligence to create three-dimensional patient-specific models assisting in surgical navigation and precision treatment. Brainlab's technologies aim to support critical surgeries and radiosurgery treatments. It was founded in 1989 and is based in Munich, Germany.
PNT Data provides a cloud-based platform to allow health plans, providers, health systems, and vendors to manage, control, and optimize the flow of healthcare information securely. This platform aims to support service, compliance, and information management within healthcare organizations. PNT Data was formerly known as Post-N-Track. It was founded in 2002 and is based in Rocky Hill, Connecticut.

Clinithink is a technology company specializing in artificial intelligence for the life sciences and healthcare sectors. The company offers AI solutions that analyze unstructured healthcare data. Clinithink serves the pharmaceutical and healthcare industries with its AI technology aimed at enhancing clinical trial processes, disease diagnosis, and revenue management. It was founded in 2009 and is based in Bridgend, United Kingdom.
Loading...

